CPhI 2013 in Frankfurt

Second generation HPMC excipient can cut costs by 60%, says Dow

Dow to showcase new polymer tech at AAPS next week

A new tableting excipient eliminates the need for wet granulation and saves up to 60% on overall manufacturing costs according to developer Dow.

Talking ADCs with SAFC, Piramal and Catalent at CPhI Frankfurt

'The sexiness of the ADC world' - CMOs talk antibody-drug hybrids at CPhI

Novasep receives US FDA approval at two EU API sites

Novasep granted US FDA approval at two EU API facilities

Dow speaks bioavailability and Bend at CPhI Frankfurt

Capsugel's purchase of Bend will strengthen partnership, says Dow

Risk-based supply chain management means more audits

Risk-based supply chain management means more audits for excipient firms

McKinsey helped to overhaul some of its practices

McKinsey consultants help to pull Patheon off the road to bankruptcy

Capsule talks softegl tech at CPhI Frankfurt

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Cobra Biologics cutting waste in fill/finish

Cobra Biologics looks to reduce volume waste during fill/finish

Frankfurt becomes Phrankfurt as drug industry gathers in Germany

Frankfurt becomes Phrankfurt as drug industry gathers in Germany

More CPhI 2013 in Frankfurt